Ulcerative Colitis, Active Moderate

Also known as: Moderate, active Ulcerative colitis / Moderate Ulcerative colitis

DrugDrug NameDrug Description
DB01014BalsalazideAn aminosalicylate used to treat ulcerative colitis.
DB06674GolimumabA TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
DB00244MesalazineAn aminosalicylate drug used to treat mild to moderate active ulcerative colitis and also to maintain remission once achieved.
DB05679UstekinumabA targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis.
DrugDrug NamePhaseStatusCount
DB17743Fecal microbiota0Unknown Status1
DB16660Izencitinib1Completed1
DB05429Bertilimumab2Unknown Status1